Viatris

VTRS US Health Care Pharmaceuticals
S&P 500
$16.51
+0.79%
Delayed · cached 15 min

Fair value analysis

Reported earnings per share are negative or zero, so the earnings-based models cannot produce a value.

Financial DNA score 46 / 100

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.